While the 2D growth of the control cell line, MCF7, was clearly stimulated by the addition of the hormone, no statistically significant changes in the proliferation rates were observed for the ERα+ ovarian cancer cells (Fig. 4B). Here, ESR1 is linked to ovarian carcinoma.